Financhill
Back

Windtree Therapeutics Quote, Financials, Valuation and Earnings

Windtree Therapeutics Price Quote

$0.55
+0.02 (+3.68%)
(Updated: December 2, 2024 at 5:55 PM ET)

Windtree Therapeutics Key Stats

Sell
23
Windtree Therapeutics (WINT) is a Sell

Day range:
$0.46 - $0.60
52-week range:
$0.45 - $19.98
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.40
P/B ratio:
1.08%

Volume:
447.5K
Avg. volume:
1.5M
1-year change:
-96.93%
Market cap:
$4.8M
Revenue:
$0
EPS:
$-16.53

How Much Does Windtree Therapeutics Make?

Data Unavailable

Is Windtree Therapeutics Growing As A Company?

Data Unavailable

Windtree Therapeutics Stock Price Performance

What Is Windtree Therapeutics 52-Week High & Low?

Windtree Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Windtree Therapeutics?

Is Windtree Therapeutics Cash Flow Positive?

  • What Is WINT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$15.3M
  • What Is Windtree Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $10.1M
  • What Is Windtree Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Windtree Therapeutics Return On Invested Capital

Data Unavailable

Windtree Therapeutics Earnings Date & Stock Price

Windtree Therapeutics Competitors

  • Who Are Windtree Therapeutics's Competitors?
    Below is a list of companies who compete with Windtree Therapeutics or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • ANI Pharmaceuticals Inc (ANIP)
    • Armata Pharmaceuticals Inc (ARMP)
    • Perspective Therapeutics Inc (CATX)
    • Protalix BioTherapeutics Inc (PLX)

Windtree Therapeutics Dividend Yield

Windtree Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -86.34%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 7.00
Upside from Last Price: 1219.51%

Major Shareholders

  • How many WINT shares are owned by institutional investors?
    771.1K WINT shares are owned by institutional investors
  • How many WINT shares are owned by insiders?
    1.5M WINT shares are owned by insiders